Actinium Pharmaceuticals ... (ATNM)
AMEX: ATNM
· Real-Time Price · USD
1.59
-0.10 (-5.92%)
At close: Sep 05, 2025, 3:59 PM
1.55
-2.82%
After-hours: Sep 05, 2025, 07:31 PM EDT
-5.92% (1D)
| Bid | 1.52 |
| Market Cap | 49.76M |
| Revenue (ttm) | 810K |
| Net Income (ttm) | -41.04M |
| EPS (ttm) | -1.31 |
| PE Ratio (ttm) | -1.22 |
| Forward PE | -1.67 |
| Analyst | Buy |
| Ask | 1.65 |
| Volume | 390,809 |
| Avg. Volume (20D) | 294,324 |
| Open | 1.68 |
| Previous Close | 1.69 |
| Day's Range | 1.52 - 1.68 |
| 52-Week Range | 1.03 - 2.41 |
| Beta | -0.30 |
About ATNM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATNM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATNM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+18.35%
Actinium Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
5 months ago
+16.53%
Actinium Pharmaceuticals shares are trading higher after the company announced it entered a research collaboration with Memorial Sloan Kettering for clinical expansion of Actimab-A's backbone therapy strategy.
